Attain Command™ + SureValve™ 6250VC (UDI 00643169143289)Recalls & reported problems
Medtronic, Inc. · Catheter 6250VC Attain Command · Class 2
All models of Attain Command + SureValve (17)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169143289), received between Oct 10, 2017 and Nov 14, 2018 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Detachment of Device or Device Component1
Patient problems
- No Known Impact Or Consequence To Patient1
- Perforation of Vessels1
- Pericardial Effusion1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 14, 2018Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED THAT THE RADIOPAQUE TIP OF THE DILATOR BROKE OFF THE CATHETER INTO A FEW PIECES INSIDE THE PATIENT DURING LEAD IMPLANT. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8068061 ↗InjuryOct 10, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE IMPLANT PROCEDURE OF THE LEFT VENTRICULAR (LV) LEAD, THE PATIENT EXPERIENCED A PERFORATION. IT WAS NOTED DURING THE PROCEDURE, THE CORONARY SINUS WAS LOCATED AND A SHEATH WAS ADVANCED INTO THE CORONARY SINUS AND A BALLOON VENOGRAPHY LOCATED THE TARGET VESSEL. THE LATERAL TARGET VESSEL WAS CANNULATED WITH A SUBSELECTING CATHETER AND THEN A SECOND SUBSELECTING CATHETER WAS ADVANCED INTO THE TARGET BUT A VENOGRAPHY REVEALED THE DISTAL PERFORATION. ALL THE LEADS AND SHEATHS WERE REMOVED. A PERICARDIAL TAP WAS PERFORMED AND DRAINED. THE POCKET WAS CLOSED AND THE PATIENT REMAINED HEMODYNAMICALLY UNSTABLE. A SECOND PERICARDIAL TAP WAS PERFORMED AT A DIFFERENCE ANGULATION. ADDITIONAL DRAINAGE OCCURRED AND ULTIMATELY THE DRAINAGE STOPPED WITH A SMALL RESIDUAL EFFUSION AND THE PATIENT REMAINED STABLE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Perforation of Vessels; Pericardial Effusion
MAUDE report 6937145 ↗
Other CATHETER, PERCUTANEOUS devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page